Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk

Prostate

Volumn 32, Issue 1, 1997, Pages 65-72

  Shibata, Atsuko ^a   Whittemore, Alice S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 reductase; African Americans; Androgen receptor gene; Asian Americans; familial aggregation; hormone metabolism

Indexed keywords

ALLELE; ASIAN AMERICAN; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN AMERICANS; CAUSALITY; ENGLAND; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; INCIDENCE; JAPAN; MALE; MUTATION; PROSTATIC NEOPLASMS; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 0030918594     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970615)32:1<65::AID-PROS9>3.0.CO;2-B     Document Type: Review

References (50)

1. American Cancer Society: "Cancer Facts and Figures, 1995." New York: American Cancer Society, 1995.
2. Whittemore AS: Prostate cancer. In Doll R, Fraumeni JF Jr, Muir CS (eds): Cancer Surveys volume 19/20: "Trends in Cancer Incidence and Mortality." Plainview, NY: Cold Spring Harbor Laboratory Press, 1994, pp 309-322.
3. Perkins CI, Morris CR, Wright WE, Young JL: Cancer incidence and mortality in California by detailed race/ethnicity, 1988-1992. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section, 1995.
4. Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM: Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 46:71-77, 1995.
5. Austin JP, Aziz H, Potters L, Thelmo W, Chen P, Choi K, Brandys M, Macchia RJ, Rotman M: Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 13:465-469, 1990.
6. Targonski PV, Guinan P, Phillips CW: Prostate cancer: The stage disadvantage in the black male. J Natl Med Assoc 83:1094-1096, 1991.
7. Lawton CA, Cantrell JE, Derus SW, Murray KJ, Byhardt RW, Wilson JF: Prostate cancer: Are racial differences in clinical stage and survival explained by differences in symptoms? Radiology 192:37-40, 1994.
8. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK: Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology 45:93-101, 1995.
9. Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF: Carcinoma of the prostate: Race as a prognostic indicator in definitive radiation therapy. Radiology 194:545-549, 1995.
10. Ragland KE, Selvin S, Merrill DW: Black-white differences in stage-specific cancer survival: Analysis of seven selected sites. Am J Epidemiol 133:672-682, 1991.
11. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF, Pandya PP, Lind ML, Bell NF: Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 71:2569-2573, 1993.
12. Powell IJ, Schwartz K, Hussain M: Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology 46:825-830, 1995.
13. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 274:1599-1605, 1995.
14. Kolonel LN, Hankin JH, Nomura AMY: Multiethnic studies of diet, nutrition, and cancer in Hawaii. In Hayashi Y, Nagao M, Sugimura T, Takayama S, Tomatis L, Wattenberg LW, Wogan GN (eds): "Diet, Nutrition, and Cancer: Proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo." Tokyo, Japan: Japan Scientific Societies Press 1986, vol. 16, pp 29-40.
15. Nomura AMY, Kolonel LN: Prostate cancer: A current perspective. Epidemiol Rev 13:200-227, 1991.
16. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin JH, Dreon DM, West DW, Teh C-Z, Paffenbarger RS Jr: Prostate cancer in relation to diet, physical activity and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87:652-661, 1995.
17. Wilding G: The importance of steroid hormones in prostate cancer. In Parker MG (ed): "Growth Regulation by Nuclear Hormone Receptors." Plainview, NY: Cold Spring Harbor Laboratory Press, 1992, pp 113-130.
18. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339:887-889, 1992.
19. Siiteri PK, Simberg NH: Changing concepts of active androgens in blood. Clin Endocrinol Metab 15:247-258, 1986.
20. Ross RK, Coetzee GA, Reichardt J, Skinner E, Henderson BE: Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer 75:1778-1782, 1995.
21. Davis DL, Russell DW: Unusual length polymorphism in human steroid 5 alpha-reductase type 2 gene (SRD5A2). Hum Mol Genet 2:820, 1993.
22. Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK: Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk. Cancer Res 55:3973-3975, 1995.
23. Granner DK: Hormones of the gonads. In Murray RK, Granner DK, Mayes PA, Rodwell VW (eds): "Harper's Biochemistry." Norwalk, CT: Appleton & Lange, 1988, pp 516-529.
24. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S: Frequent detection of codon 877 mutation in the rogen receptor gene in advanced prostate cancers. Cancer Res 54:2861-2864, 1994.
25. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R: Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253, 1992.
26. Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER: Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198:74-80, 1994.
27. Chamberlain NL, Driver ED, Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186, 1994.
28. Irvine RA, Yu MC, Ross RK, Coetzee GA: The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937-1940, 1995.
29. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Silverman DT, Brown LM, Hoover RN, Fraumeni JF: Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 60:361-364, 1995.
30. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh C-Z, Stamey T: Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141:732-740, 1995.
31. Narod S, Dupont A, Cuasn L, Diamond P, Gomez J-L, Suburu R, Labrie F: The impact of family history on early detection of prostate cancer (letter). Nature Med 1:99-101, 1995.
32. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Breast cancer linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695, 1994.
33. Langston A, Stanford J, Wiklund K, Thompson JD, Blazez RG, Ostrander EA: Germline BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58:881-885, 1996.
34. Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C, Holt JT: BRCA1 is secreted and exhibits properties of a granin. Nature Genet 12: 303-308, 1996.
35. Gudmundsson J, Johannesdottir G, Bergthorsson JT, Arason A, Ingvarsson S, Egilsson V, Barkardottir RB: Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res 55:4830-4832, 1995.
36. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371, 1992.
37. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR: Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:47-69, 1982.
38. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH: Familiality of cancer in Utah. Cancer Res 54:2378-2385, 1994.
39. Bergerheim USR, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220, 1991.
40. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990.
41. Atkins NB, Baker MC: Chromosome studies of five cancers of the prostate. Hum Genet 70:359-364, 1985.
42. Collins VP, Kunimi K, Bergerheim U, Ekman P: Molecular genetics and human prostatic carcinoma. Acta Oncol 30:181-185, 1991.
43. Brothman AR, Patel AM, Peehl DM, Schellhammer PF: Analysis of prostate tumor cultures using fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 52:180-185, 1992.
44. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109, 1992.
45. Woolf CM: An investigation of the familial aspects of carcinoma of the prostate. Cancer 13:739-744, 1960.
46. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE: Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nature Med 1:827-829, 1995.
47. Sun S, Narod SA, Aprikian A, Ghadirian P, Labrie F: Androgen receptor and familial prostate cancer [letter]. Nature Med 1:848-849, 1995.
48. Meikle AW, Bishop DT, Stringham JD, West DW: Quantitating generic and nongenetic factors that determine plasma sex steroid variation in normal male twins. Metabolism 35:1090-1095, 1987.
49. Meikle AW, Stringham JD, Bishop DT, West DW: Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab 67:104-109, 1988.
50. Bishop DT, Meikle AW, Slattery ML, Stringham JD, Ford MH, West DW: The effect of nutritional factors on sex hormone levels in male twins. Genet Epidemiol 5:43-59, 1988.